Home > Press > IMEC Board Reports a Successful 2006
Abstract:
During today's General Assembly, the IMEC Board confirms that 2006 was an excellent year at all levels. IMEC was able to maintain its position as a leading nanoelectronics research institute and is constantly adapting to the changing semiconductor landscape to offer research programs the industry needs.
The hard work, skills, and devotion of the IMEC researchers resulted in many great results. Evidence of this is given by an 8.6% increase of the number of publications in prestigious journals and conference contributions to 1652, often achieved in collaboration with universities in Flanders and abroad. A large number of these papers were presented at renowned conferences in 2006 (4 at ISSCC, 7 at VLSI, 11/7 at ESSDERC/ESSCIRC, 17 at IEDM, 7 at GLOBECOM, 13 at DATE, 19 at EPVSEC , 4 at IMAPS, 7 at ECOC, and others). The number of invited papers and lectures increased by 43 percent to 139. Also, 97 patents were submitted and 51 patents were granted in 2006.
To achieve these important results, IMEC could count on 1489 coworkers, a number which represents a growth of 6.2 percent as compared to 2005. Twenty-two percent are guest researchers and residents from the academic and industrial world.
The year 2006 was also positive from a financial side. IMEC's total revenue (profit & loss) was 227 million Euro, of which 35.5 million Euro consists of the research grant from the Flanders Government. A major part of the total revenue is related to the successful implementation of the core partnership program on (sub-)32nm scaling. For example, in 2006 IMEC welcomed Micron as its ninth core partner.
"Continuous interaction with the industry gives IMEC a clear view on the pre-competitive research the changing semiconductor industry needs. IMEC has taken these changes as new opportunities," said Dr. Gilbert Declerck, President and CEO of IMEC. "We increased the focus on memory technology, so that now both logic and memory (flash and DRAM) are investigated in our (sub-)32nm core program. With an increasing number of IDMs moving to a fablite model, we also extended our programs to answer the needs of all semiconductor players from IDMs, foundries to fab-lite companies. In 2006, we have prepared an important reorganization to maximize our multi-disciplinary research and in this way answering the increased demand for extra functionality in systems and chips. We also expect a lot from the bio-nano convergence where we explore an active collaboration with institutes that have expertise in the fields of medicine and molecular biology to complement our own expertise in micro- and nanoelectronics engineering. Furthermore, Apollo, the successor of our multi-mode multimedia (M4) program has been defined together with important industrial players."
####
About IMEC
IMEC is a world-leading independent research center in nanoelectronics and nanotechnology. Its research focuses on the next generations of chips and systems, and on the enabling technologies for ambient intelligence. IMEC’s research bridges the gap between fundamental research at universities and technology development in industry. Its unique balance of processing and system know-how, intellectual property portfolio, state-of-the-art infrastructure and its strong network of companies, universities and research institutes worldwide position IMEC as a key partner for shaping technologies for future systems.
IMEC is headquartered in Leuven, Belgium, has a sister company in the Netherlands, IMEC Nederland, concentrating on wireless autonomous transducer solutions, and has representatives in the US, China and Japan. Its staff of more than 1500 people includes more than 500 industrial residents and guest researchers. In 2006, its revenue (profit & loss) was EUR 227 million. Further information on IMEC can be found at http://www.imec.be .
For more information, please click here
Contacts:
IMEC Corporate Communications
Katrien Marent, +32 16 28 18 80
or
Maestro Marketing & PR
Barbara Kalkis, +1-308-996-9975
Copyright © Business Wire 2007
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Chip Technology
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||